Bär & Karrer advised Lonza Group, a globally active manufacturer of pharmaceutical, biotech and specialty ingredients, on the sale of its entire stake in MicroMacinazione — a Ticino-based contract manufacturer of micronization active ingredients for
Tags :Andrea Ziswiler
Marriott International and Italian luxury wellness hospitality specialist Lefay have signed binding agreements to enter a joint venture, bringing the Lefay brand into Marriott’s portfolio. The joint venture would entail an equal partnership aimed
Bär & Karrer advised Airsol, part of SOL Group — an Italian spcialist in the production, research and marketing of technical and medical gases and homecare services sector — on its acquisition of VitalAire Switzerland from
Bär & Karrer advised Swiss technology company Logol as Lagfin – Campari Group’s controlling shareholder – completed a strategic investment in the company. The context A specialist in AI and cloud-based SaaS solutions for
Bär & Karrer advised technology company TeamSystem, a specialist in digital solutions for management of businesses and professionals, on the acquisition of Swiss-based Arca24.com , a software house specialised in the development and commercialization
Bär & Karrer advised HAS Healthcare Advanced Synthesis and its sole shareholder in the acquisition of Chemholding due and its subsidiaries, including its main operative company Cerbios-Pharma. The company HAS Healthcare Advanced Synthesis is
On 10 October 2024, the City of Bellinzona successfully completed its inaugural issuance of CHF 125 million 1.05 percent bonds due 2035. The bonds have been listed on the SIX Swiss Exchange. Bank Vontobel was the sole lead manager for
As of January 1, 2024, Bär & Karrer announces the election of Faton Aliu, Rocco Rigozzi, and Andrea Ziswiler as partners, alongside Stephanie Walter as counsel. The addition of these accomplished legal professionals not only enhances
Fidinam Group Holding and Swiss Finance & Property Group (SFP) have acquired minority stakes and entered into a strategic partnership in relation to Erop Generation, a new real estate group founded in May 2023 by Andrea
Helsinn Group, a fully integrated, global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases, has closed a financing agreement with Oberland
